Evidence map›Paper›PMID 16495532›Full record

ArticleInfection and immunity2006

Vaccination of mice with gonococcal TbpB expressed in vivo from Venezuelan equine encephalitis viral replicon particles.

Christopher E Thomas, Weiyan Zhu, Cornelius N Van Dam, Nancy L Davis, Robert E Johnston, P Frederick Sparling

Open access · greenAbstract read
In one paragraph

Article in Infection and immunity, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Review
  3. Clinical microbiology reviews · 2024
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Enhancement of protein expression by alphavirus replicons by designing self-replicating subgenomic RNAs.Proceedings of the National Academy of Sciences of the United States of America · 2014
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Christopher E ThomasUniversity of North Carolina at Chapel Hill, Dept. of Medicine, Div. of Infectious Disease Research, 8341 Medical Biomolecular Research Bldg., 103 Mason Farm Road, CB 7031, Chapel Hill, NC 27599, USA. cet@med.unc.edu
Weiyan Zhu
Cornelius N Van Dam
Nancy L Davis
Robert E Johnston
P Frederick Sparling
Office of Infectious Diseases · USUniversity of North Carolina at Chapel Hill · US

Funding

Trichomonas Typing SystemU19AI031496 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI HOBBS, MARCIA METZGAR · 1995 to 2014
$24.9M
LACTOFERRIN RECEPTOR AND GONOCOCCAL PATHOGENESISR01AI026837 · NIAID · UNIVERSITY OF NORTH CAROLINA CHAPEL HILL · PI SPARLING, PHILIP FREDERICK · 1999 to 2003
$1.4M
MICROBIAL PATHOGEN GENOME PROJECT--NEISSERIA GONORRHOEAER01AI038399 · NIAID · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI DYER, DAVID W. · 1995 to 1998
–
NIAID NIH HHS 5 R01 AI26837NIAID NIH HHS 5 U19 AI31496NIAID NIH HHS AI38399NIAID NIH HHS R01 AI026837NIAID NIH HHS U19 AI031496
6 · The paper itself

Abstract

We investigated the immunogenicity of gonococcal transferrin binding protein B (TbpB) expressed with and without a eukaryotic secretion signal from a nonpropagating Venezuelan equine encephalitis virus replicon particle (VRP) delivery system. TbpB was successfully expressed in baby hamster kidney (BHK) cells, and the presence of the eukaryotic secretion signal not only apparently increased the protein's expression but also allowed for extracellular localization and glycosylation. Mice immunized with VRPs produced significant amounts of serum antibody although less than the amounts produced by mice immunized with recombinant protein. The response of mice immunized with VRPs encoding TbpB was consistently more Th1 biased than the response of mice immunized with recombinant protein alone. Boosting with recombinant protein following immunization with TbpB VRPs resulted in higher specific-antibody levels without altering the Th1/Th2 bias. Most of the immunization groups produced significant specific antibody binding to the intact surface of the homologous Neisseria gonorrhoeae strain. Immunization with TbpB VRPs without a eukaryotic secretion signal generated no measurable specific antibodies on the genital mucosal surface, but inclusion of a eukaryotic secretion signal or boosting with recombinant protein resulted in specific immunoglobulin G (IgG) and IgA in mucosal secretions after TbpB VRP immunization. The TbpB VRP system has potential for an N. gonorrhoeae vaccine.

Indexed as

AnimalsAntibodies, BacterialAntigens, BacterialBacterial VaccinesEncephalitis Virus, Venezuelan EquineFemaleGonorrheaImmunoglobulin AMiceMice, Inbred BALB CNeisseria gonorrhoeaeRecombinant ProteinsRepliconTransferrin-Binding Protein BVaccinationVaginaAntibodies, BacterialAntigens, BacterialBacterial VaccinesImmunoglobulin ARecombinant ProteinsTransferrin-Binding Protein B

Identifiers

PMID16495532
PMCPMC1418633
OpenAlexW2138280343

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.